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South Africa (SA) has seen a rapid increase 
in COVID-19 infections in recent weeks, 
with cases exceeding 40 000 in early June 
and anticipated to escalate rapidly as 
lockdown is eased. The country also has 
the largest HIV burden globally, and poor 
maternal and child health indices in many 
parts. Although early indications were 
that COVID-19 infection does not worsen 
pregnancy and birth outcomes,[1-4] recent 
reports have raised fresh concerns.[5] Preterm 
birth,[6-8] neonatal pneumonia[9-11] and cases 
of vertical transmission and postpartum 
infections have been reported, including in 
SA.[1,11-15] Some maternal deaths related to 
COVID-19 have occurred, possibly linked 
to haemodynamic changes immediately 
postpartum[2,16] and/or to the thrombogenic 
nature of both pregnancy and COVID-
19.[17-19] Maternal wellbeing in pregnant 
women with COVID-19 infection is a major 
concern, as these women often have high 
anxiety about infecting their newborn child, 
and may experience challenging interactions 
with healthcare providers and community 
stigma.[2,18] Most evidence on COVID-19 
and pregnancy to date is limited to case 
series, involves only symptomatic women 
without HIV, and is almost exclusively from 
high-income countries. Cohort data across 
a range of settings and population groups 
are the only means of fully understanding 
the natural history, clinical disease spectrum 
and risks of COVID-19 in pregnant women, 
fetuses and infants.[19,20]
Pregnant women have multiple inter-
actions with the health system, with impor-
tant implications for SARS-CoV-2 trans-
mission to and from health workers and 
other patients and to newborns.[21-23] One 
study in New York, USA, for example, 
performed universal SARS-CoV-2 testing 
in all women in an obstetric ward. In total, 
15% of the 221 women were SARS-CoV-
2-positive, and 88% of those who were 
infected were asymptomatic.[24] In another 
study in Connecticut, USA, 2.9% of ~750 
women tested at delivery were COVID-19-
positive and asymptomatic.[25] It is clear that 
an infection control strategy and research 
agenda that includes asymptomatic pregnant 
women is necessary.[26] This editorial 
describes a set of surveillance and research 
activities among pregnant women that could 
provide key evidence to inform the response 
to COVID-19 in SA.
Sentinel surveillance 
among pregnant women
Sentinel surveillance of infectious disease 
among pregnant women is commonly used as 
an indicator of disease burden at a population 
level. This approach was used during the 
height of the HIV epidemic in sub-Saharan 
Africa and elsewhere to track the epidemic 
and derive population-based HIV prevalence 
estimates.[27-29] With serial surveys in sentinel 
clinics one can track population-level 
incidence, quantify case detection rates and 
assess the relative effectiveness of different 
control measures. Identifying infections 
in pregnant women attending antenatal 
clinics may allow for timely identification 
and control of local clusters of infections[30] 
and for evidence-based decisions around 
lockdown deconfinement in different 
locales. [31-33] Alternative surveillance methods 
such as household surveys are logistically 
challenging, costly, often have high refusal 
rates, have a low yield, and are unable to 
give local estimates unless sample sizes are 
considerable.[34-36]
COVID-19 surveillance in antenatal clin-
ics may be particularly important in heavily 
affected provinces and in areas that are 
densely populated. These include informal 
settlements and areas with predominantly 
high-rise apartment buildings, such as 
Hillbrow in Johannesburg,[37] which may 
be vulnerable to the kind of outbreaks 
that occurred in New York City. Similarly, 
surveillance in SA should prioritise 
economic hubs with overcrowded informal 
densely populated settlements that may have 
poor access to health services and cover 
a range of geographical areas, including 
metropolitan hubs in all provinces. 
Surveillance could neatly be layered onto 
existing initiatives and collaborations, 
such as the recently launched hospital-
focused Maternal and Perinatal Outcomes 
of Novel Coronavirus in Pregnancy Study 
and a national pregnancy exposure registry, 
planned for implementation in 19 facilities 
in Gauteng, KwaZulu-Natal and Western 
Cape provinces.[38] Establishing sentinel site 
pregnancy exposure registries, harmonised 
across sites and consolidating routine clinical 
data on pregnancy exposures and outcomes, 
provides a platform onto which additional 
surveillance activities such as with COVID-
19 can be built as the need arises.
Surveillance activities would need to adopt 
innovative approaches to COVID-19 testing 
given the limited availability of testing at 
present. Pregnant women with symptoms 
suggestive of COVID-19 would be prioritised 
for individualised polymerase chain reaction 
(PCR) testing of nasopharyngeal swabs, 
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Proposed sentinel site surveillance of COVID-19 in pregnant women. The figure represents diverse 
environments including high-rise buildings, informal settlements, RDP (government subsidy) housing 
and the potential for pregnant women to represent COVID-19 infection within the broader population. 
(Red dots = COVID-19 infection; green dots = COVID-19-uninfected; ANC clinic = antenatal clinic.)
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as per national guidelines. Pooled testing among asymptomatic 
pregnant women may be an efficient alternative for diagnosis of acute 
infection and is increasingly being used in SA and elsewhere. [39-41] 
This approach appears cost-effective up to a prevalence of SARS-
CoV-2 of ~10%.[39] Nasopharyngeal or serological samples of ~10 
women could be ‘pooled’ into one specimen. If that tests negative, it 
can be assumed that all 10 samples are negative. If the pooled test is 
positive, each sample in the pool would then be tested individually to 
detect the positive case(s). It is anticipated that serological testing will 
become available shortly and form the mainstay of active surveillance, 
and until then samples could be stored for later testing. In time, 
once barriers to COVID-19 testing have been addressed, ‘universal 
testing’ of pregnant women, a cornerstone of HIV programmes, may 
become a key element in COVID-19 control. Since antenatal cohorts 
represent diverse populations of women, testing of blood routinely 
collected may also provide opportunity for COVID-19 and other 
disease screening and testing.
Ideally, serological testing would be performed on serial maternal 
specimens, cord blood and infant blood to determine immune 
dynamics, which would have implications both for population 
seroprevalence and for informing the potential impact of future 
vaccination strategies. Although widespread sampling falls outside 
routine practice in public sector health services, practical approaches 
may be required, including limiting maternal sampling to certain 
time points, such as delivery, to optimally leverage routine blood tests 
such as maternal HIV testing and HIV viral load testing at delivery, 
infant birth HIV-PCR and stored dry blood spots.
Cohorts of pregnant women with 
COVID-19
Surveillance in sentinel antenatal clinics offers a unique opportunity 
to establish population-based prospective cohorts of women and 
children, which would be the optimal means of defining key COVID-
19 epidemiological parameters such as asymptomatic infection rates 
and case severity.[20] These cohorts can also identify signals of adverse 
maternal or infant outcomes following COVID-19 infection.[42] 
Natural history and birth outcomes could be disaggregated by HIV 
status, and between women living with HIV who initiate antiretroviral 
therapy in pregnancy and those on long-term treatment. In this cohort, 
ideally PCR sampling and serological sampling would be performed 
serially to determine immune dynamics and antibody kinesis. 
Here again, superimposing SARS-CoV-2-specific investigations on 
existing surveillance infrastructure that includes all pregnant women 
at a facility (such as the National Pregnancy Exposure Registry) 
could conserve resources and provide appropriate denominators for 
calculations. These platforms provide an opportunity for testing the 
performance of health interventions targeting COVID-19 such as 
therapeutics and vaccines in this important patient group. Then, once 
these modalities become more widely available, these systems serve 
to assess the safety of these products post-marketing in pregnant and 
postpartum women and their infants.
Conclusions
In summary, surveillance and cohort studies among pregnant and 
postnatal women and their infants could provide critical information. 
This includes estimates of COVID-19 infection rates in pregnant 
women, which are likely to be reflective of the disease burden in 
the broader community; an understanding of the natural history of 
COVID-19 in pregnant and postnatal women and their infants; and 
an assessment of innovative testing strategies such as pooled PCR and 
serological testing. Additionally, such data could determine whether 
COVID-19 disease manifests differently in women living with and 
without HIV infection. Lastly, this approach would provide a platform 
to evaluate whether or not pregnant women should be prioritised to 
be included in COVID-19 therapeutic and vaccine studies because 
of enhanced concerns about maternal and infant wellbeing. The 
considerable experience in SA of HIV research and prevalence 
surveys among pregnant women, together with the pregnancy registry 
infrastructure being developed, set the scene for a robust COVID-19 
surveillance system and nested cohort studies in antenatal clinics.
Lee Fairlie, Shobna Sawry, Faeezah Patel
Wits Reproductive Health and HIV Institute, Faculty of Health 
Sciences, University of the Witwatersrand, Johannesburg, South Africa
Jennifer E Balkus
Department of Epidemiology, School of Public Health, University of 
Washington, Seattle, USA
Emma Kalk
Centre for Infectious Disease Epidemiology and Research, School 
of Public Health and Family Medicine, Faculty of Health Sciences, 
University of Cape Town, South Africa
Portia Mutevedzi
Respiratory and Meningeal Pathogens Research Unit, South African 
Medical Research Council, Johannesburg, South Africa; and School 
of Public Health, Faculty of Health Sciences, University of the 
Witwatersrand, Johannesburg, South Africa
Karl-Günter Technau
Empilweni Services and Research Unit, Rahima Moosa Mother and 
Child Hospital, Johannesburg, South Africa; and Department of 
Paediatrics and Child Health, Faculty of Health Sciences, University of 
the Witwatersrand, Johannesburg, South Africa
Laura M Yates
KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), 
School of Laboratory Medicine and Medical Sciences, University of 
KwaZulu-Natal, Durban, South Africa; and Department of Human 
Genetics, Inkosi Albert Luthuli Central Hospital, Durban, South Africa
Amy Slogrove
Department of Paediatrics and Child Health, Faculty of Medicine and 
Health Sciences, Stellenbosch University, Cape Town, South Africa
Daynia Ballot
School of Clinical Medicine, Faculty of Health Sciences, University of 
the Witwatersrand, Johannesburg, South Africa
Rosella M Bandini
Department of Paediatrics and Child Health, Faculty of Health 
Sciences, University of the Witwatersrand, and Charlotte Maxeke 
Johannesburg Academic Hospital, Johannesburg, South Africa
Ushma Mehta
Centre for Infectious Disease Epidemiology and Research, School 
of Public Health and Family Medicine, Faculty of Health Sciences, 
University of Cape Town, South Africa
Dhayendre Moodley
Department of Obstetrics and Gynaecology, School of Clinical 
Medicine, Faculty of Health Sciences, University of KwaZulu-Natal, 
Durban, South Africa
731       August 2020, Vol. 110, No. 8
EDITORIAL
Ottancia Mhlongo
HAST Unit, Strategic Health Programmes, KwaZulu-Natal 
Department of Health, South Africa
Samantha Budram
Maternal-Fetal Medicine, Inkosi Albert Luthuli Central Hospital, 
Durban, South Africa; and University of KwaZulu-Natal, Durban,  
South Africa
Salome Maswime
Global Surgery Division, Department of Surgery, Faculty of Health 
Sciences, University of Cape Town, South Africa
Valerie Vannevel
SAMRC Maternal and Infant Health Care Strategies Unit, University 
of Pretoria, South Africa
Helen Rees, Matthew Chersich
Wits Reproductive Health and HIV Institute, Faculty of Health 
Sciences, University of the Witwatersrand, Johannesburg, South Africa
mchersich@wrhi.ac.za
1. Chen H, Guo J, Wang C, et al. Clinical characteristics and intrauterine vertical transmission potential 
of COVID-19 infection in nine pregnant women: A retrospective review of medical records. Lancet 
2020;395(10226):809-815. https://doi.org/10.1016/S0140-6736(20)30360-3
2. Chen L, Li Q, Zheng D, et al. Clinical characteristics of pregnant women with Covid-19 in Wuhan, 
China. N Engl J Med 2020;385(25):e100. https://doi.org/10.1056/NEJMc2009226
3. Elshafeey F, Magdi R, Hindi N, et al. A systematic scoping review of COVID-19 during pregnancy and 
childbirth. Int J Gynaecol Obstet 2020;150(1):47-52 https://doi.org/10.1002/ijgo.13182
4. Ren H, Zhao L, Zhang A, et al. Early forecasting of the potential risk zones of COVID-19 in China’s 
megacities. Sci Total Environ 2020;729:138995. https://doi.org/10.1016/j.scitotenv.2020.138995
5. Donders F, Lonnee-Hoffmann R, Tsiakalos A, et al. ISIDOG recommendations concerning COVID-19 
and pregnancy. Diagnostics 2020;10(4):243. https://doi.org/10.3390/diagnostics10040243
6. Della Gatta AN, Rizzo R, Pilu G, et al. Coronavirus disease 2019 during pregnancy: A systematic review 
of reported cases. Am J Obstet Gynecol 2020;223(1):36-41. https://doi.org/10.1016/j.ajog.2020.04.013
7. Di Mascio D, Khalil A, Saccone G, et al. Outcome of coronavirus spectrum infections (SARS, MERS, 
COVID-19) during pregnancy: A systematic review and meta-analysis. Am J Obstet Gynecol MFM 
2020;2(2 Suppl):100107. https://doi.org/10.1016/j.ajogmf.2020.100107
8. Yang Z, Wang M, Zhu Z, et al. Coronavirus disease 2019 (COVID-19) and pregnancy: A systematic 
review. J Matern Fetal Med 2020 (epub 30 April 2020). https://doi.org/10.1080/14767058.2020.17
59541
9. Baud D, Giannoni E, Pomar L, et al. COVID-19 in pregnant women: Authors’ reply. Lancet Infect Dis 
2020 (epub 17 March 2020). https://doi.org/10.1016/S1473-3099(20)30192-4
10. Khan S, Jun L, Nawsherwan, et al. Association of COVID-19 with pregnancy outcomes in health-care 
workers and general women. Clin Microbiol Infect 2020 (epub 8 April 2020). https://doi.org/10.1016/j.
cmi.2020.03.034
11. Zimmermann P, Curtis N. COVID-19 in children, pregnancy and neonates: A review of 
epidemiologic and clinical features. Pediatr Infect Dis J 2020;39(6):469-477. https://doi.org/10.1097/
inf.0000000000002700
12. Cheruiyot I, Henry BM, Lippi G. Is there evidence of intra-uterine vertical transmission potential of 
COVID-19 infection in samples tested by quantitative RT-PCR? Eur J Obstet Gynecol Reprod Biol 
2020;249:100-101. https://doi.org/10.1016/j.ejogrb.2020.04.034
13. Li D, Wang D, Dong J, et al. False-negative results of real-time reverse-transcriptase polymerase 
chain reaction for severe acute respiratory syndrome coronavirus 2: Role of deep-learning-based CT 
diagnosis and insights from two cases. Korean J Radiol 2020;21(4):505-508. https://doi.org/10.3348/
kjr.2020.0146
14. Kimberlin DW, Stagno S. Can SARS-CoV-2 infection be acquired in utero? More definitive evidence is 
needed. JAMA 2020;323(18):1788-1789. https://doi.org/10.1001/jama.2020.4868
15. Adebayo B. A two-day-old baby has died of Covid-19 in South Africa. CNN, 21 May 2020. https://
edition.cnn.com/2020/05/21/africa/south-africa-baby-death-coronavirus-intl/index.html (accessed 
29 June 2020).
16. Chen R, Zhang Y, Huang L, et al. Safety and efficacy of different anesthetic regimens for parturients with 
COVID-19 undergoing cesarean delivery: A case series of 17 patients. Can J Anaesth 2020;67(6):655-
663. https://doi.org/10.1007/s12630-020-01630-7
17. Di Renzo GC, Giardina I. COVID-19 in pregnancy: Consider thromboembolic disorders and 
thromboprophylaxis. Am J Obstet Gynecol 2020;223(1):135. https://doi.org/10.1016/j.ajog.2020.04.017
18. Corbett GA, Milne SJ, Hehir MP, et al. Health anxiety and behavioural changes of pregnant women 
during the COVID-19 pandemic. Eur J Obstet Gynecol Reprod Biol 2020;249:96-97. https://doi.
org/10.1016/j.ejogrb.2020.04.022
19. Breslin N, Baptiste C, Gyamfi-Bannerman C, et al. COVID-19 infection among asymptomatic and 
symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New 
York City hospitals. Am J Obstet Gynecol MFM 2020;2(2 Suppl):00118. https://doi.org/10.1016/j.
ajogmf.2020.100118
20. Buekens P, Alger J, Breart G, et al. A call for action for COVID-19 surveillance and research during 
pregnancy. Lancet Glob Health 2020;8(7):e877-e878. https://doi.org/10.1016/S2214-109X(20)30206-0
21. Ashokka B, Loh MH, Tan CH, et al. Care of the pregnant woman with COVID-19 in labor and 
delivery: Anesthesia, emergency cesarean delivery, differential diagnosis in the acutely ill parturient, 
care of the newborn, and protection of the healthcare personnel. Am J Obset Gynecol 2020;223(1):66-
74. https://doi.org/10.1016/j.ajog.2020.04.005
22. Capanna F, Haydar A, McCarey C, et al. Preparing an obstetric unit in the heart of the epidemic strike 
of COVID-19: Quick reorganization tips. J Matern Fetal Med 2020 (epub 12 April 2020). https://doi.
org/10.1080/14767058.2020.1749258
23. Chawla D, Chirla D, Dalwai S, et al. Perinatal-neonatal management of COVID-19 infection – 
Guidelines of the Federation of Obstetric and Gynecological Societies of India (FOGSI), National 
Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP). Indian Pediat 
2020;57(6):536-548.
24. Sutton D, Fuchs K, D’Alton M, et al. Universal screening for SARS-CoV-2 in women admitted for 
delivery. N Engl J Med 2020;382(22):2163-2164. https://doi.org/10.1056/NEJMc2009316
25. Campbell KH, Tornatore JM, Lawrence KE, et al. Prevalence of SARS-CoV-2 among patients admitted 
for childbirth in southern Connecticut. JAMA 2020;323(24):2520-2522. https://doi.org/10.1001/
jama.2020.8904
26. Goudsmit J. The paramount importance of serological surveys of SARS-CoV-2 infection and 
immunity. Eur J Epidemiol 2020;35(4):331-333. https://doi.org/10.1007/s10654-020-00635-2
27. Sangal B, Kumar P, Dhingra N. HIV prevalence trend from HIV sentinel surveillance over a decade 
in India: An overview. Indian J Public Health 2018;62(2):138-142. https://doi.org/10.4103/ijph.
IJPH_151_16
28. GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, 
age-specific mortality, and life expectancy, 1970 - 2016: A systematic analysis for the Global 
Burden of Disease Study 2016. Lancet 2017;390(10100):1084-1150. https://doi.org/10.1016/S0140-
6736(17)31833-0
29. Eaton JW, Rehle TM, Jooste S, et al. Recent HIV prevalence trends among pregnant women and all 
women in sub-Saharan Africa: Implications for HIV estimates. AIDS 2014;28(Suppl 4):S507-S514. 
https://doi.org/10.1097/QAD.0000000000000412
30. Thompson RN. Novel coronavirus outbreak in Wuhan, China, 2020: Intense surveillance is vital for 
preventing sustained transmission in new locations. J Clin Med 2020;9(2):498. https://doi.org/10.3390/
jcm9020498
31. Xiao SY, Wu Y, Liu H. Evolving status of the 2019 novel coronavirus infection: Proposal of conventional 
serologic assays for disease diagnosis and infection monitoring. J Med Virol 2020;92(5):464-467. 
https://doi.org/10.1002/jmv.25702
32. Anelli F, Leoni G, Monaco R, et al. Italian doctors call for protecting healthcare workers and boosting 
community surveillance during covid-19 outbreak. BMJ 2020;368:m1254. https://doi.org/10.1136/
bmj.m1254
33. Dimeglio C, Loubes JM, Deporte B, et al. The SARS-CoV-2 seroprevalence is the key factor for 
deconfinement in France. J Infect 2020 (in press). https://doi.org/10.1016/j.jinf.2020.04.031
34. Gutreuter S, Igumbor E, Wabiri N, et al. Improving estimates of district HIV prevalence and burden 
in South Africa using small area estimation techniques. PLoS ONE 2019;14(2):e0212445. https://doi.
org/10.1371/journal.pone.0212445
35. Kirakoya-Samadoulougou F, Nagot N, Samadoulougou S, et al. Declining HIV prevalence in parallel 
with safer sex behaviors in Burkina Faso: Evidence from surveillance and population-based surveys. 
Glob Health Sci Pract 2016;4(2):326-335. https://doi.org/10.9745/GHSP-D-16-00013
36. Marsh KA, Nyamukapa CA, Donnelly CA, et al. Monitoring trends in HIV prevalence among young 
people, aged 15 to 24 years, in Manicaland, Zimbabwe. J Int AIDS Soc 2011;14(1):27. https://doi.
org/10.1186/1758-2652-14-27
37. Rees H, Delany-Moretlwe S, Scorgie F, et al. At the heart of the problem: Health in Johannesburg’s 
inner-city. BMC Public Health 2017;17(Suppl 3):554. https://doi.org/10.1186/s12889-017-4344-2
38. Mehta U, Kalk E, Fairlie L, et al. Why South Africa urgently needs to support the development of 
pregnancy exposure registries. S Afr Med J 2019;109(5):294-295. https://doi.org/10.7196/SAMJ.2019.
v109i5.14008
39. Abdalhamid B, Bilder CR, McCutchen EL, et al. Assessment of specimen pooling to conserve SARS 
CoV-2 testing resources. Am J Clin Pathol 2020;153(6):715-718. https://doi.org/10.1093/ajcp/aqaa064
40. Eis-Hubinger AM, Honemann M, Wenzel JJ, et al. Ad hoc laboratory-based surveillance of SARS-
CoV-2 by real-time RT-PCR using minipools of RNA prepared from routine respiratory samples. J 
Clin Virol 2020;127:104381. https://doi.org/10.1016/j.jcv.2020.104381
41. Pouwels KB, Roope LSJ, Barnett A, et al. Group testing for SARS-CoV-2: Forward to the past? 
PharmacoEconomics Open 2020;4:207-210. https://doi.org/10.1007/s41669-020-00217-8
42. Alvarado MG, Schwartz DA. Zika virus infection in pregnancy, microcephaly, and maternal and fetal 
health: What we think, what we know, and what we think we know. Arch Path Lab Med 2017;141(1):26-
32. https://doi.org/10.5858/arpa.2016-0382-RA
S Afr Med J 2020;110(9):728-731. https://doi.org/10.7196/SAMJ.2020.v110i9.15012
